Eupraxia Pharmaceuticals Inc. (EPRX) stock
EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.62−0.72 (-9.81%)
Close on Nov 17, 2026Market cap $399.15MP/E –Yield –
Eupraxia Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
For fiscal 2025 it was -$28.55M.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$28.55M | – |
| FY2024 | Dec 31, 2024 | -$29.99M | – |
| FY2023 | Dec 31, 2023 | -$20.75M | – |
| FY2022 | Dec 31, 2022 | -$14.40M | – |
See a number that looks wrong?